• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.19% Nasdaq Up0.08%




    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Glenmark Pharmaceuticals Ltd. (GLENMARK.NS)

    1,033.60 Down 23.35(2.21%) 5:59AM EDT
    Key StatisticsGet Key Statistics for:
    Data provided by Capital IQ, except where noted.
    Valuation Measures 
    Market Cap (intraday)5:280.41B
    Enterprise Value (Oct 7, 2015)3:317.00B
    Trailing P/E (ttm, intraday):58.52
    Forward P/E (fye Mar 31, 2017)1:N/A
    PEG Ratio (5 yr expected)1:N/A
    Price/Sales (ttm):4.27
    Price/Book (mrq):9.56
    Enterprise Value/Revenue (ttm)3:4.72
    Enterprise Value/EBITDA (ttm)6:29.33
    Financial Highlights 
    Fiscal Year
    Fiscal Year Ends:Mar 31
    Most Recent Quarter (mrq):Jun 30, 2015
    Profit Margin (ttm):7.16%
    Operating Margin (ttm):14.32%
    Management Effectiveness
    Return on Assets (ttm):N/A
    Return on Equity (ttm):N/A
    Income Statement
    Revenue (ttm):67.21B
    Revenue Per Share (ttm):246.54
    Qtrly Revenue Growth (yoy):11.10%
    Gross Profit (ttm):43.37B
    EBITDA (ttm)6:10.81B
    Net Income Avl to Common (ttm):4.81B
    Diluted EPS (ttm):17.66
    Qtrly Earnings Growth (yoy):3.30%
    Balance Sheet
    Total Cash (mrq):7.75B
    Total Cash Per Share (mrq):28.55
    Total Debt (mrq):38.00B
    Total Debt/Equity (mrq):126.66
    Current Ratio (mrq):N/A
    Book Value Per Share (mrq):110.59
    Cash Flow Statement
    Operating Cash Flow (ttm):N/A
    Levered Free Cash Flow (ttm):N/A
    View Financials
    Income Statement - Balance Sheet - Cash Flow

    Trading Information 
    Stock Price History
    52-Week Change3:49.58%
    S&P500 52-Week Change3:0.56%
    52-Week High (Aug 21, 2015)3:1,262.90
    52-Week Low (Oct 8, 2014)3:697.05
    50-Day Moving Average3:1,070.99
    200-Day Moving Average3:966.27
    Share Statistics
    Avg Vol (3 month)3:1,309,920
    Avg Vol (10 day)3:702,353
    Shares Outstanding5:271.29M
    % Held by Insiders1:N/A
    % Held by Institutions1:N/A
    Shares Short 3:N/A
    Short Ratio 3:N/A
    Short % of Float 3:N/A
    Shares Short (prior month)3:N/A
    Dividends & Splits
    Forward Annual Dividend Rate4:N/A
    Forward Annual Dividend Yield4:N/A
    Trailing Annual Dividend Yield3:N/A
    Trailing Annual Dividend Yield3:N/A
    5 Year Average Dividend Yield4:N/A
    Payout Ratio4:N/A
    Dividend Date3:N/A
    Ex-Dividend Date4:N/A
    Last Split Factor (new per old)2:N/A
    Last Split Date3:N/A

    See Key Statistics Help for definitions of terms used.
    Abbreviation Guide: K = Thousands; M = Millions; B = Billions
    mrq = Most Recent Quarter (as of Jun 30, 2015)
    ttm = Trailing Twelve Months (as of Jun 30, 2015)
    yoy = Year Over Year (as of Jun 30, 2015)
    lfy = Last Fiscal Year (as of Mar 31, 2015)
    fye = Fiscal Year Ending
    1 Data provided by Thomson Reuters
    2 Data provided by EDGAR Online
    3 Data derived from multiple sources or calculated by Yahoo! Finance
    4 Data provided by Morningstar, Inc.
    5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
    6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

    Currency in INR.